Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Common rapid antigen tests detect Delta and Omicron SARS-CoV-2 strains effectively

A recent study by US researchers shows how the performance of rapid antigen tests to diagnose severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is not inferior among individuals infected with the Omicron variant compared to the Delta variant. The study is currently available on the medRxiv* preprint server while it undergoes peer review.

7 Mar 2022

How does COVID-19 affect patients with idiopathic pulmonary fibrosis?

A new study discusses the outcomes of idiopathic pulmonary fibrosis patients with confirmed SARS-CoV-2 infection.

6 Mar 2022

Diabetes and the mTOR pathway in COVID-19 patients

A new study discusses the possible etiopathogenetic mechanisms associated with diabetes that could enhance the severity of COVID-19.

6 Mar 2022

Myocarditis and pericarditis in COVID-19 vaccine recipients

A new study provides valuable evidence towards this end, using surveillance data to provide the best estimates of these outcomes.

6 Mar 2022

Combating COVID cytokine storm with targeted nucleic acid therapies

Researchers examine current nucleic acid-based treatments against COVID-19 and their methods of action.

6 Mar 2022

Incidence of post-surgical complications before and during COVID-19 pandemic

Scientists compare post-surgical complications before and during the COVID-19 pandemic.

6 Mar 2022

CD4 T-cell immunity active six months into COVID-19 convalescence

A new paper explores the presence of CD4 T-cell-mediated adaptive immunity against SARS-CoV-2 in late convalescence.

6 Mar 2022

Disruption of sleep and circadian rhythm can increase the chances of contracting a virus

A recent study explores the effect of sleep and circadian rhythm dispersion on mouse lung transcriptome after six of hours sleep deprivation.

6 Mar 2022

Aldosterone levels undetectably low in hospitalized COVID-19 patients

A new study reports finds very low aldosterone levels in a subset of COVID-19 patients.

6 Mar 2022

Omicron-specific mRNA vaccine generates immune responses in mice, hamsters and Macaques

Researchers develop an Omicron variant mRNA vaccine that is be more potent in generating nAbs as compared to other available vaccines.

6 Mar 2022

Longitudinal analysis of CD4+ T cells and antibody responses to common cold coronaviruses

Scientists have recently revealed that memory T cell responses to common cold coronaviruses stably persist for a long time.

4 Mar 2022

Study does not find association between hematological parameters and COVID-19-related hospitalization

Researchers examine the genetic factors influencing hematological parameters in SARS-CoV-2 infection.

4 Mar 2022

Dynamics of SARS-CoV-2 transmission at Purdue University

Researchers performed genomic surveillance of SARS-CoV-2 and its variants in a university setting.

4 Mar 2022

Patterns of bat β-coronaviruses evolution

Researchers conduct an evolutionary analysis of SARS-CoV-2-related bat β-coronavirus genomes.

4 Mar 2022

Gas chromatography-ion mobility spectrometry helps diagnose COVID-19 and predict disease severity

Researchers assess the ability of GC-IMS to differentiate between COVID-19 and other respiratory infections, as well as predict disease severity.

4 Mar 2022

RT-LAMP assay shows promise as point-of-care SARS-CoV-2 detection assay across multiple settings

Researchers evaluate the feasibility and robustness of an optimized RT-LAMP SARS-CoV-2 detection assay across multiple resource-restricted settings.

4 Mar 2022

Angiotensin-converting enzyme 2-based mutant decoy effectively reduces COVID-19 in mice

Researchers engineered a mutant ACE2 decoy that effectively protected human lung epithelia from SARS-CoV-2 infection by competitively binding to its spike protein.

3 Mar 2022

Clinical trial report endorses nitazoxanide as a safe drug for moderately ill COVID-19 patients

Researchers tested the safety and efficacy of 600 mg oral dose of nitazoxanide in mild or moderately ill COVID-19 patients.

3 Mar 2022

Convalescent plasma therapy shows no significant impact on COVID-19 recovery and outcomes

Researchers conduct a multi-center study involving hospitalized COVID-19 patients to gather information on the rationale use of convalescent plasma.

3 Mar 2022

8G3 broad-spectrum antibody effective against all SARS-CoV-2 variants, including Omicron

Researchers assess the efficacy of 8G3, a B-cell neutralizing antibody against SARS-CoV-2 variants, including the most recent Omicron variant.

3 Mar 2022

Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Common rapid antigen tests detect Delta and Omicron SARS-CoV-2 strains effectively

How does COVID-19 affect patients with idiopathic pulmonary fibrosis?

Diabetes and the mTOR pathway in COVID-19 patients

Myocarditis and pericarditis in COVID-19 vaccine recipients

Combating COVID cytokine storm with targeted nucleic acid therapies

Incidence of post-surgical complications before and during COVID-19 pandemic

CD4 T-cell immunity active six months into COVID-19 convalescence

Disruption of sleep and circadian rhythm can increase the chances of contracting a virus

Aldosterone levels undetectably low in hospitalized COVID-19 patients

Omicron-specific mRNA vaccine generates immune responses in mice, hamsters and Macaques

Longitudinal analysis of CD4+ T cells and antibody responses to common cold coronaviruses

Study does not find association between hematological parameters and COVID-19-related hospitalization

Dynamics of SARS-CoV-2 transmission at Purdue University

Patterns of bat β-coronaviruses evolution

Gas chromatography-ion mobility spectrometry helps diagnose COVID-19 and predict disease severity

RT-LAMP assay shows promise as point-of-care SARS-CoV-2 detection assay across multiple settings

Angiotensin-converting enzyme 2-based mutant decoy effectively reduces COVID-19 in mice

Clinical trial report endorses nitazoxanide as a safe drug for moderately ill COVID-19 patients

Convalescent plasma therapy shows no significant impact on COVID-19 recovery and outcomes

8G3 broad-spectrum antibody effective against all SARS-CoV-2 variants, including Omicron

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Newsletters you may be interested in